BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.
Graham Watson, Executive Chair at InnoScot Health, explains how the firm’s special 20th anniversary celebrates international healthcare innovation success.
Plastic pollution has been an issue since the 1960s, but when mask-wearing, single-use plastics and hand sanitiser bottles became the norm, things only got worse.
CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms.
Dr Bahman Nedjat-Shokouhi, founder and CEO of Medefer, discusses how virtual outpatient care is the future of the NHS and how we need to prioritise funding for digital technologies that can pave the way for elective recovery.
Geospatial technology, or geographic information systems (GIS), has become an essential instrument in multiple areas today: agriculture and aviation, construction and commerce, climate research and law enforcement—the list could go on.
Rob Banathy, Senior Product Manager at NHS Digital, explains how his team developed a lateral flow device digital reader service that can detect nearly twice the number of positive COVID-19 cases during early infection compared to the human eye.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
Experts from Oxford Immune Algorithmics highlight how the Immune system has come under the spotlight in Human Biology, particularly as a consequence of the COVID-19 pandemic.
